Phylogenetic evidence of extensive spatial mixing of diverse HIV-1 group M lineages within Cameroon but not between its neighbours.

Cameroon HIV-1 group M (HIV-1M) evolution phylogenetic viral diversity

Journal

Virus evolution
ISSN: 2057-1577
Titre abrégé: Virus Evol
Pays: England
ID NLM: 101664675

Informations de publication

Date de publication:
2024
Historique:
received: 21 11 2023
revised: 12 07 2024
accepted: 28 08 2024
medline: 10 10 2024
pubmed: 10 10 2024
entrez: 10 10 2024
Statut: epublish

Résumé

From the perspective of developing relevant interventions for treating HIV and controlling its spread, it is particularly important to comprehensively understand the underlying diversity of the virus, especially in countries where the virus has been present and evolving since the cross-species transmission event that triggered the global pandemic. Here, we generate and phylogenetically analyse sequences derived from the

Identifiants

pubmed: 39386075
doi: 10.1093/ve/veae070
pii: veae070
pmc: PMC11463025
doi:

Types de publication

Journal Article

Langues

eng

Pagination

veae070

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press.

Déclaration de conflit d'intérêts

None declared.

Auteurs

Célestin Godwe (C)

Center of Research for Emerging and Re-Emerging Diseases (CREMER), Institute of Medical Research and Study of Medicinal Plants (IMPM), Yaoundé, PO Box. 906 Yaoundé, Cameroon.
Department of Biochemistry, University of Douala, Douala, PO Box. 24157 Douala, Cameroon.

Oumarou H Goni (OH)

Center of Research for Emerging and Re-Emerging Diseases (CREMER), Institute of Medical Research and Study of Medicinal Plants (IMPM), Yaoundé, PO Box. 906 Yaoundé, Cameroon.
Department of Microbiology, Faculty of Sciences, University of Yaoundé 1, Yaoundé, PO Box. 812 Yaoundé, Cameroon.

James E San (JE)

KwaZulu-Natal Research Innovation and Sequencing Platform, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban 4001, South Africa.
Duke Human Vaccine Institute, Duke University, Durham, NC 27710, United States.

Nelson Sonela (N)

Center of Research for Emerging and Re-Emerging Diseases (CREMER), Institute of Medical Research and Study of Medicinal Plants (IMPM), Yaoundé, PO Box. 906 Yaoundé, Cameroon.
Chantal BIYA International Reference Centre for Research on HIV/AIDS prevention and management (CIRCB), Yaoundé PO Box. 3077 Yaoundé, Cameroon.
Weill Cornell Medical College, Department of Medicine, Cornell University, New York, NY 10021, United States.

Mérimé Tchakoute (M)

Programmes de Santé et développement au sein du Groupement de la Filière Bois du Cameroun, PO Box 495, Yaoundé, Cameroon.

Aubin Nanfack (A)

Chantal BIYA International Reference Centre for Research on HIV/AIDS prevention and management (CIRCB), Yaoundé PO Box. 3077 Yaoundé, Cameroon.

Francioli K Koro (FK)

Department of Biochemistry, University of Douala, Douala, PO Box. 24157 Douala, Cameroon.

Christelle Butel (C)

TransVIHMI, Université de Montpellier, IRD, INSERM, 911 Avenue Agropolis, Montpellier, Montpellier cedex 34394, France.

Nicole Vidal (N)

TransVIHMI, Université de Montpellier, IRD, INSERM, 911 Avenue Agropolis, Montpellier, Montpellier cedex 34394, France.

Ralf Duerr (R)

Department of Medicine, Division of Infectious Diseases and Immunology, NYU Grossman School of Medicine, New York, NY 10016, United States.
Vaccine Center, NYU Grossman School of Medicine, New York, NY 10016, United States.
Department of Microbiology, NYU Grossman School of Medicine, New York, NY 10016, United States.

Darren P Martin (DP)

Department of Integrative Biomedical Sciences, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Cape Town 7700, South Africa.

Tulio de Oliveira (T)

KwaZulu-Natal Research Innovation and Sequencing Platform, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban 4001, South Africa.
Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch 7600, South Africa.

Martine Peeters (M)

TransVIHMI, Université de Montpellier, IRD, INSERM, 911 Avenue Agropolis, Montpellier, Montpellier cedex 34394, France.

Marcus Altfeld (M)

Universitätsklinikum Hamburg-Eppendorf, Hamburg, Hamburg 20251, Germany.

Ahidjo Ayouba (A)

Center of Research for Emerging and Re-Emerging Diseases (CREMER), Institute of Medical Research and Study of Medicinal Plants (IMPM), Yaoundé, PO Box. 906 Yaoundé, Cameroon.
TransVIHMI, Université de Montpellier, IRD, INSERM, 911 Avenue Agropolis, Montpellier, Montpellier cedex 34394, France.

Thumbi Ndung'u (T)

HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu Natal, Durban 4013, South Africa.
Africa Health Research Institute (AHRI), Durban 4001, South Africa.
Ragon Institute of MGH, MIT and Harvard University, Cambridge MA 02139, United States.
Division of Infection and Immunity, University College London, London WC1E 6BT, United Kingdom.

Marcel Tongo (M)

Center of Research for Emerging and Re-Emerging Diseases (CREMER), Institute of Medical Research and Study of Medicinal Plants (IMPM), Yaoundé, PO Box. 906 Yaoundé, Cameroon.
HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu Natal, Durban 4013, South Africa.

Classifications MeSH